Biostax Corp.
BTAX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $474 | $14 | $153 | $126 |
| G&A Expenses | $957 | $1,149 | $586 | $760 |
| SG&A Expenses | $957 | $1,149 | $586 | $760 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54 | $0 | $0 | $1 |
| Operating Expenses | $1,485 | $1,163 | $738 | $887 |
| Operating Income | -$1,485 | -$1,163 | -$738 | -$887 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$878 | -$2,372 | $4,324 | $2,476 |
| Pre-Tax Income | -$2,363 | -$3,536 | $3,586 | $1,589 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,363 | -$3,536 | $3,586 | $1,589 |
| % Margin | – | – | – | – |
| EPS | -0.03 | -0.1 | 7.43 | 3.44 |
| % Growth | 70% | -101.3% | 116% | – |
| EPS Diluted | -0.03 | -0.1 | 0.38 | 0.11 |
| Weighted Avg Shares Out | 83,510 | 36,290 | 483 | 461 |
| Weighted Avg Shares Out Dil | 83,510 | 36,290 | 9,394 | 461 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $168 | $120 | $211 | $653 |
| Depreciation & Amortization | $54 | $0 | $0 | $1 |
| EBITDA | -$2,140 | -$3,415 | $3,797 | $2,069 |
| % Margin | – | – | – | – |